Skip to content

Other current assets at other companies

Merck & Co. logo
Merck & Co.MRK
Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
United Therapeutics logo
United TherapeuticsUTHR

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.47B+152%
Enterprise value$2.45B+157%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s other current assets?
Trevi Therapeutics, Inc. (TRVI) reported other current assets of $2.12M in Q1 2026.
How has Trevi Therapeutics, Inc.'s other current assets changed year-over-year?
Trevi Therapeutics, Inc.'s other current assets increased by 154.4% year-over-year, from $834K to $2.12M.
What is the long-term trend for Trevi Therapeutics, Inc.'s other current assets?
Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s other current assets has grown at a 51.8% compound annual growth rate (CAGR), from $265K to $2.13M.